Rivaroxaban demonstrates strong efficacy and safety profile in phase III study in children with thromboembolism

Phase III EINSTEIN-Jr. study in children concludes the largest pediatric thromboembolism program delivering results consistent with those in adults ...

Address by Werner Baumann

Chairman of the Board of Management

Address by Wolfgang Nickl

Member of the Board of Management ...

Address by Werner Baumann

Chairman of the Board of Management ...

Address by Werner Baumann

Chairman of the Board of Management ...

Address by Werner Baumann

Chairman of the Board of Management ...

Shaping Agriculture to Benefit Farmers, Consumers, and our Planet

Liam Condon, Member of the Board of Management Bayer AG / Dr. Bob Reiter, Head of Research and Development, Crop Science, a division of Bayer ...

Address by Werner Baumann, Chairman of the Board of Management, and Liam Condon, President Crop Science Division

Address by Werner Baumann

Chairman of the Board of Management

Address by Werner Baumann

Chairman of the Board of Management ...

Address by Johannes Dietsch

Member of the Board of Management ...

Address by Werner Baumann

Chairman of the Board of Management

Shaping the Future of Farming

Liam Condon, Member of the Board of Management Bayer AG and President of the Crop Science Division / Adrian Percy, Head of Research and Development, Crop Science Division